Introduction {#Sec1}
============

In development, cell differentiation leads to establishment of cell identities through the sequential action of transcription factors (TFs) acting as specification or determination factors. These processes involve master TFs that primarily act on the epigenome to open new regulatory chromatin landscapes. This is achieved by a unique class of TF, pioneer factors. Unlike canonical TFs, pioneers bind "closed" chromatin, trigger chromatin opening, and thus allow binding of other TFs.

For example, Foxa1 is essential for liver fate and binds regulatory sequences before gene activation^[@CR1],[@CR2]^. Ebf1 also acts as a pioneer factor during B cell development, and Neurod1 and Ascl1 (Mash1) were suggested to function as pioneer factors during neural development^[@CR3],[@CR4]^. Ectopic expression of pioneer factors is sufficient to drive trans-differentiation; thus, C/EBPα can direct trans-differentiation of pre-B cells into macrophages^[@CR5]^. The most extreme example is the reprogramming of fibroblasts into induced pluripotent stem cells through action of the pioneer factors Oct4, Klf4, and Sox2^[@CR6],[@CR7]^.

The ability to open chromatin has been implicitly considered as a core property of pioneer TFs and this would allow nonpioneer binding to newly accessible sites. Whether nonpioneers play a role in pioneer-driven chromatin opening has not been assessed. Here, we used normal and perturbed pituitary differentiation to investigate the pioneer model and establish the specific and/or overlapping functions of the differentiation regulators Pax7 (pioneer) and Tpit (nonpioneer).

Two pituitary lineages express the hormone precursor pro-opiomelanocortin (POMC), the melanotropes and corticotropes. Both require Tpit for POMC expression and cell fate determination^[@CR8],[@CR9]^. Indeed, Tpit implements a secretory cell transcriptional program by activation of scaling factors for translation and secretory organellogenesis^[@CR10]^. While sharing the secretory POMC identity, corticotropes and melanotropes differ by their functions as these POMC-expressing lineages control corticosteroidogenesis and pigmentation, respectively^[@CR11]^. The pioneer Pax7 drives melanotrope specification^[@CR12]^ through deployment of a melanotrope-specific enhancer repertoire^[@CR13]^.

Here, we first establish that the two POMC lineages share a transcriptional program that is distinct from other pituitary cells and that in addition they each have a unique program of gene expression. We then show that these two layers of identity (shared and lineage-specific) are reflected at the level of chromatin accessibility and that the Shared POMC chromatin landscape requires Tpit. Further, Tpit is required for the opening of the Pax7-dependent melanotrope chromatin landscape, indicating that Pax7 and Tpit act together during melanotrope differentiation. Finally, Pax7 and Tpit have complementary roles as only Pax7 can bind heterochromatin, while Tpit binding is needed for chromatin opening. In summary, we propose that the essence of pioneer action is the ability to recognize and bind DNA sites in closed chromatin, whereas cooperating nonpioneer TFs, such as Tpit, may drive chromatin opening.

Results {#Sec2}
=======

Single-cell RNA reveals pituitary transcriptional diversity {#Sec3}
-----------------------------------------------------------

The pituitary is a highly specialized organ where each lineage serves as a hormone-producing factory. Each cell type is dedicated to the regulation of a specific endocrine organ and responds to specific signals from the hypothalamus and body. We used single-cell RNA-sequencing (scRNAseq) to decipher the transcriptional complexity of the different pituitary lineages. For each lineage, hormone-coding messenger RNAs (mRNAs) are so abundant that they appear as peaks in complementary DNA (cDNA) libraries (Supplementary Fig. [1a](#MOESM1){ref-type="media"}). Profiling of adult mouse male pituitary cells (Supplementary Fig. [1b](#MOESM1){ref-type="media"}) was achieved by plotting single-cell data using t-distributed stochastic neighbor embedding (t-SNE), a common method^[@CR14]^ that uses dimensionality reduction to cluster together cells with similar transcriptional profiles (Fig. [1a](#Fig1){ref-type="fig"}). This showed that cells expressing the same pituitary hormone cluster together and that they all express Pitx1, a marker of the oral ectoderm origin of the pituitary^[@CR11]^ (Fig. [1b](#Fig1){ref-type="fig"} and Supplementary Fig. [1c](#MOESM1){ref-type="media"}). We identified 12 clusters composed of endocrine and non-endocrine cells (Fig. [1c](#Fig1){ref-type="fig"}). Cluster 1 corresponds to somatotropes as they express the growth hormone (*Gh*) gene. Lactotropes that produce prolactin (Prl) are found in cluster 2. Clusters 4 and 5 correspond to melanotropes and corticotropes, respectively; both express the *POMC* gene, yet only melanotropes express *Pcsk2*. Gonadotropes that express the *Lhβ* gene are in cluster 8. We also detected thyrotropes as *Tshβ*-expressing cells; however, they did not appear as a separate cluster (Fig. [1c](#Fig1){ref-type="fig"}). The pituitary stem cells that express Sox2^[@CR15]^ are found in cluster 7. Although our study aimed at defining the transcriptome of the different pituitary lineages, we also uncovered several non-endocrine cells within the pituitary tissue that do not express Pitx1 (Fig. [1b](#Fig1){ref-type="fig"}). We identified endothelial cells (cluster 9), macrophages (cluster 10), posterior pituicytes (cluster 11), and pericytes (cluster 12). Cluster 3 is fragmented in three different groups of cells that express either GH, prolactin, POMC, or Lhβ. We performed differential expression analysis between each sub-cluster 3 and its matching cell type in order to define these subsets. In all cases, cells of these subsets are specifically depleted of ribosomal proteins and enriched for mitochondrial RNA. This was shown to be an artifact of tissue dissociation^[@CR16]^ and to represent cells affected by the preparation: we excluded cluster 3 from following analyses.Fig. 1Transcriptional complexity of the pituitary adult gland. **a** t-Distributed stochastic neighbor embedding (t-SNE) map (t-distributed stochastic neighbor embedding) plot of the 9269 profiled pituitary cells colored by the 12 clusters identified using unsupervised *k*-means clustering. Cluster identification included expression of the hallmarks gene(s) indicated between parenthesis and the markers shown in **c**. **b** t-SNE map showing color-coded Pitx1 expression. **c** t-SNE map showing color-coded expression of indicated markers for the major pituitary lineages. **d** Heatmap showing normalized expression of the 1000 most differentially expressed genes (*p* value \<0.05, fold change (FC) \>2 and minimum number of unique molecular identifier (UMI) \>0.3) in clusters representing the different endocrine and progenitor cells (clusters 1, 2, 4, 5, 7, and 8). Rows are centered; unit variance scaling is applied to rows. Both rows and columns are clustered using correlation distance and average linkage

We then compared the transcriptomes of the different pituitary lineages by performing differential expression analysis between clusters 1, 2, 4, 5, 7, and 8. Genes with two-fold differential expression between each cluster (*p* value \<0.05 and minimum 0.2 unique molecular identifier (UMI) in at least one pooled cluster) are shown as a heatmap (Fig. [1d](#Fig1){ref-type="fig"}). The Sox2+ stem cell niche is the most transcriptionally divergent from other pituitary lineages based on correlation clustering analyses. The two Pit1-dependent lineages, the lactotropes and somatotropes, are the most different compared to the two POMC lineages and gonadotropes that cluster together. Within the latter group, corticotropes and melanotropes are more transcriptionally correlated together than with gonadotropes. Thus, the two POMC lineages, melanotropes and corticotropes, have both a shared and a specific transcriptional program.

Lineage-specific chromatin landscapes identify regulators {#Sec4}
---------------------------------------------------------

We next aimed to identify *cis*-regulatory elements that regulate the transcriptional identity of pituitary lineages. We used assay for transposase-accessible chromatin using sequencing (ATACseq)^[@CR17]^ to identify the putative regulatory elements accessible in each lineage. We complemented our previously published datasets of purified melanotrope and corticotrope ATACseq with accessibility profiles for gonadotropes and anterior lobe (AL) cells. Gonadotropes were fluorescence-activated cell sorting (FACS) purified from transgenic pituitaries expressing the LHβ-Cerulean transgene^[@CR18]^. As control, we isolated the remaining AL cells that are mostly composed of a combination of Pit1-dependent somatotropes and lactotropes. Interestingly, we found that the promoters of hormone genes *POMC*, *αGSU*, *Gh*, and *Prl*, as well as lineage specifiers *Tpit* (*Tbx19*), *Pax7*, *SF1* (*Nr5a1*), and *Pit1* show lineage-specific accessibility (Fig. [2a](#Fig2){ref-type="fig"} and Supplementary Fig. [2a--c](#MOESM1){ref-type="media"}). However, the *Pcsk2* promoter is accessible in all pituitary lineages but its numerous distal accessible sites (putative enhancers) are only accessible in melanotropes. Globally, we identified 98926 open chromatin regions across the pituitary lineages (Fig. [2b](#Fig2){ref-type="fig"}). Segregation of lineage-specific accessibility yielded 33,451 regions opened in all lineages, 14,025 regions opened in a combination of three lineages, 20,374 in two lineages, and finally 31,076 opened in only one lineage. Thus, there are regions specifically accessible in melanotropes, corticotropes, gonadotropes, or in the AL. In accordance with the close transcriptional correlation between melanotropes and corticotropes, we also found shared regions accessible in both melanotropes and corticotropes (Shared POMC), but closed in gonadotropes and AL. Finally, we identified 13,130 pituitary-specific sites that are closed in embryonic stem cells, as well as a set of 20,321 regions accessible in both pituitary and embryonic stem (ES) cells (Supplementary Fig. [2d](#MOESM1){ref-type="media"}). These ubiquitous peaks are for the majority (58%) composed of promoter elements (Supplementary Fig. [2e](#MOESM1){ref-type="media"}), while regions opened in two or in only one pituitary lineage are mostly distal elements (94 and 96%, respectively). This reinforces the idea that promoter accessibility is established early during differentiation. Further, this suggests that lineage-specific opening of promoters tends to be an exception and may be involved in restricting appropriate expression of critical genes such as hormone-coding genes and lineage specifiers.Fig. 2Lineage-specific chromatin access reveals lineage regulators. **a** Genome browser view (Integrative Genomics Viewer (IGV)) of assay for transposase-accessible chromatin using sequencing (ATACseq) profiles at genes marking pituitary lineages: Shared pro-opiomelanocortin (POMC) markers (green), melanotrope (red), or gonadotrope (orange). The *SF1* promoter is indicated by an arrow. **b** Heatmaps showing ATACseq signals (reads per kilobase of transcript, per million mapped reads (RPKM)) across the different pituitary lineages in a 4 kb window around the ATACseq peak center indicated by an arrow. Colored boxes indicate peaks specifically enriched in the indicated lineage. **c** Box-plot showing expression (unique molecular identifier (UMI)) of gene markers of the POMC lineages across the different lineages. Center lines show medians; box limits indicate the 25th and 75th percentiles; whiskers extend to 1.5 times the interquartile range from the 25th to 75th percentiles. **d** Average profiles of ATACseq signals at POMC-specific ATACseq peaks. **e** Box-plot of distances between the TSS of POMC-specific genes and the closest ATACseq peak in POMC, melanotropes and gonadotrope cells. Box-plot features as in **c**. **f** Motif enriched (assessed by HOMER) under POMC-specific ATACseq peaks and not found in other subsets. **g** Box-plot showing expression (UMI) of melanotrope gene markers across the different lineages. Box-plot features as in **c**. **h** Average profiles of ATACseq signals at melanotrope-specific ATACseq peaks. **i** Box-plot of distances between the transcription start site (TSS) of melanotrope-specific genes and the closest ATACseq peak in POMC, melanotrope, and gonadotrope cells. Box-plot features as in **c**. **j** Motif enriched (assessed by HOMER) under melanotrope-specific ATACseq peaks and not found in other subsets. **k** Average profiles of ATACseq signals at cortico-, gonado-, and AL-specific ATACseq peaks. **l** Motifs enrichment (assessed by HOMER) under cortico-, gonado-, and AL-specific ATACseq peaks and not found in other subsets

Comparison of the relationship between the Shared POMC transcriptional program (shown as UMI expression units in each lineage in Fig. [2c](#Fig2){ref-type="fig"}) and lineage-specific accessibility (as average metaplots of all ATACseq peak signals per cell in Fig. [2d](#Fig2){ref-type="fig"}) shows that Shared POMC-specific gene promoters tend to be closer to both Shared POMC- and melano-specific open regions (Fig. [2e](#Fig2){ref-type="fig"}) and are enriched for the motif of the lineage specifier Tpit (Fig. [2f](#Fig2){ref-type="fig"} and Supplementary Fig. [2f](#MOESM1){ref-type="media"}). Melanotrope genes are also close to their lineage-specific open chromatin regions and their lineage-specific chromatin landscape is enriched for the motif of their lineage specifier Pax7 (Fig. [2g--j](#Fig2){ref-type="fig"}). Similar relationships were found for the Pit1-dependent AL lineages, the corticotropes, and the gonadotropes (Fig. [2k, l](#Fig2){ref-type="fig"}).

Pax7 is required for phenotypic features of melanotropes {#Sec5}
--------------------------------------------------------

The two POMC lineages have shared and specific transcriptional programs and open chromatin landscapes. Their most obvious similarity is expression of the hormone precursor POMC as well as expression of the terminal differentiation factor Tpit. However, POMC expression varies between these two lineages with low (blue) and high expression (red) cells in scRNAseq analyses (Fig. [3a](#Fig3){ref-type="fig"}). Indeed, POMC is more highly expressed in Pax7-expressing melanotropes compared to GR (nr3c1)-expressing corticotropes as shown in t-SNE and differential expression Volcano plots (Fig. [3a, b](#Fig3){ref-type="fig"}). Analysis of the POMC-EGFP (enhanced green fluorescent protein)^[@CR19]^ transgenic pituitaries (Fig. [3c](#Fig3){ref-type="fig"}) also showed high- and low-expressing cells. Indeed, IL (melanotropes) transgenic pituitary cells have much higher EGFP levels compared to most EGFP-positive corticotrope cells of the AL (Fig. [3d](#Fig3){ref-type="fig"}). This indicates that the transgene expressed in both melanotropes and corticotropes is subject to cell-type-specific regulation and can be used as a surrogate phenotypic readout. Strikingly in a *Pax7−/−* background, melanotropes express the EGFP transgene at the same level as in AL corticotropes (Fig. [3d, e](#Fig3){ref-type="fig"}). Melanotropes are also typically larger and have a more complex organelle content than corticotropes as assessed by forward scatter (FSC) and side scatter (SSC) distributions in FACS profiles and this is also lost in Pax7-deficient mice (Supplementary Fig. [3a, b](#MOESM1){ref-type="media"}). Thus, all three melanotrope features (high POMC expression, large cell size, and granularity) are fully dependent on Pax7 consistent with the switch in gene expression^[@CR12],[@CR13]^ and virtually all melanotropes switch to a corticotrope phenotype in *Pax7−/−* mice (Supplementary Fig. [3c](#MOESM1){ref-type="media"}). However, the proportion of total EGFP-positive cells in AL or IL is not affected by loss of Pax7 (Supplementary Fig. [3d](#MOESM1){ref-type="media"}). Thus, Pax7 implements melanotrope but not the Shared POMC properties, which are under the control of Tpit^[@CR9]^.Fig. 3Pax7 implements melanotrope features onto a shared pro-opiomelanocortin (POMC) cell identity. **a** t-Distributed stochastic neighbor embedding (t-SNE) map of adult pituitary cells colored for expression of the POMC lineage regulator Tpit (Tbx19). Enlarged panels showing two clusters of POMC cells with high and low POMC levels, melanotropes expressing Pax7, and corticotropes expressing GR. **b** Volcano plot showing differential transcription factor gene expression (*p* value versus log 2 fold change (FC)) between the high versus low POMC-expressing cells. GR and Pax7 are highlighted. **c** Experimental scheme to assess Pax7 dependence of melanotrope phenotypic features. Transgenic mice expressing POMC-EGFP (enhanced green fluorescent protein) were crossed into *Pax7−/−* mice and compared to wild-type (WT). The two pituitary lobes were dissected for each genotype and analyzed by fluorescence-activated cell sorting (FACS). **d** Representative FACS profiles showing cell populations with different POMC-EGFP transgene levels in intermediate (IL) and anterior lobes (AL) of *WT* (*n* = 5) and *Pax7 KO* (knockout) (*n* = 3) pituitaries. Blue and red shading labels low and high EGFP levels, respectively. **e** Bar graph showing ratios of EGFP signals in *WT* IL, *Pax7 KO* AL, *Pax7 KO* IL compared to *WT* AL. The analyses included five *WT* and three *Pax7 KO* replicates. *P* values were computed using unpaired two-sided *t* test

Pax7 and Tpit are required for opening enhancer landscapes {#Sec6}
----------------------------------------------------------

We next sought to uncouple the specific roles of Pax7 and Tpit for implementation of the Shared POMC and the melanotrope-specific chromatin landscapes. To do so, we performed ATACseq on IL cells from mice of genetic backgrounds lacking one or both alleles of *Pax7* and/or *Tpit*. We used *Pax7* and *Tpit* double heterozygote littermates as control; these show minimal differences compared to wild-type (WT) animals (Supplementary Fig. [4a](#MOESM1){ref-type="media"}) and these differentially accessible peaks are enriched for the same motifs (AP1, Pax7, Tbox) as other subsets. We found that melanotrope-specific peaks (Fig. [2b](#Fig2){ref-type="fig"}) are lost in *Pax7−/−;Tpit+/−* IL, whereas they are present in WT or double heterozygotes (Fig. [4a](#Fig4){ref-type="fig"}) in agreement with previous data^[@CR13]^ that showed Pax7 requirement for accessibility of melanotrope regulatory modules. Also, we found that Tpit is required for the open status of the Shared POMC chromatin landscape (Fig. [4b](#Fig4){ref-type="fig"}). This suggests that Tpit is involved in the pioneering process of the Shared POMC lineage enhancers. For example, POMC gene expression critically relies on Tpit and accordingly both its promoter and enhancer accessibility strongly depend on Tpit but not on Pax7 (Fig. [4c](#Fig4){ref-type="fig"}). This is also true for the promoter of POMC-specific gene *Tnxb* and the Tpit-dependent enhancer^[@CR10]^ of the *Creb3l2* gene (Fig. [4c](#Fig4){ref-type="fig"}). These sites do not require Pax7 for accessibility and similarly for most of the Shared POMC enhancers (Supplementary Fig. [4b](#MOESM1){ref-type="media"}). Thus, Tpit is required for opening the Shared POMC regulatory modules, while Pax7 is only required for melanotrope enhancers.Fig. 4Pax7 and Tpit are required for opening cognate enhancer landscapes. **a** Read density heatmaps showing assay for transposase-accessible chromatin using sequencing (ATACseq) signals (reads per kilobase of transcript, per million mapped reads (RPKM)) across the different pituitary lineages in a 4 kb window centered at melanotrope-specific ATAC peaks (left panel). Right panel shows corresponding ATACseq heatmaps in the ILs of *WT*, *Pax7*^*+/−*^*;Tpit*^*+/−*^ (labeled Pax7^*+/−*^) and *Pax7*^*−/−*^*;Tpit*^*+/−*^ (labeled Pax7^−/−^) mice. **b** Read density heatmaps showing ATACseq signals (RPKM) across the different pituitary lineages in a 4 kb window centered at pro-opiomelanocortin (POMC)-specific ATAC peaks (left panel). Right panel shows corresponding ATACseq heatmaps in the intermediate lobe of *WT*, *Pax7*^*+/−*^*;Tpit*^*+/−*^ (labeled Pax7^*+/−*^) and *Pax7*^*−/−*^*;Tpit*^*+/−*^ (labeled Pax7^−/−^) mice. **c** Genome browser view (Integrative Genomics Viewer (IGV)) of ATACseq profiles at POMC-specific ATACseq peaks in the different pituitary lineages and in ILs of *Pax7*^*+/−*^*;Tpit*^*+/−*^, *Pax7*^*−/−*^*;Tpit*^*+/−*^, and *Pax7*^*+/−*^*;Tpit*^*−/−*^ mice

Tpit is required for Pax7-dependent chromatin opening {#Sec7}
-----------------------------------------------------

In order to define and compare the Pax7 and Tpit-dependent ATACseq landscapes, we performed differential enrichment analysis (*p* \< 0.05 and fold changes \>2) and found 16,024 sites altered in *Tpit−/−* IL (Fig. [5a](#Fig5){ref-type="fig"}). Most changes are decreased accessibility (12,573 sites) and these show greater quantitative differences compared to sites with increased accessibility (3451 sites). Analysis of these Tpit-dependent sites revealed two subsets, one dependent and one independent of Pax7 (Fig. [5b](#Fig5){ref-type="fig"}). In both Tpit-dependent subsets, chromatin accessibility in *Pax7−/−;Tpit−/−* IL is the same as in *Tpit−/−*. In order to ascertain the reliability of these analyses, we validated dependence on Pax7, Tpit, or both by quantitative PCR (qPCR) analyses of three independent ATACseq libraries of each genotype (Supplementary Fig. [5](#MOESM1){ref-type="media"}). Principal component analysis using all Tpit-regulated sites shows that most of the variance between samples (77%) is explained by component 1 (Fig. [5c](#Fig5){ref-type="fig"}). Consistent with the heatmaps of Fig. [5b](#Fig5){ref-type="fig"}, *WT* and *Pax7+/−;Tpit+/−* cluster together, while *Pax7* knockout are between WT and *Tpit*-knockout samples. Thus, a subset of Tpit chromatin targets are also dependent on Pax7. We then focused on Pax7-dependent chromatin access to assess whether co-dependency on Tpit and Pax7 is a general feature of Pax7-dependent sites. We found 7057 Pax7-dependent sites (Fig. [5d](#Fig5){ref-type="fig"}): most changes are decreased accessibility (6112 sites) and these are greater effects compared to increased sites (945 sites). Strikingly, and unlike Tpit-dependent accessibility, virtually all Pax7-dependent sites are also dependent on Tpit (Fig. [5e](#Fig5){ref-type="fig"} and Supplementary Fig. [4b](#MOESM1){ref-type="media"}). Accordingly, principal component analysis of Pax7-dependent sites (Fig. [5f](#Fig5){ref-type="fig"}) showed that *Pax7*-knockout samples cluster with *Tpit* knockout and *Pax7* knockout on component 1 (79% of variance). This indicates that in vivo, Tpit is absolutely required for the establishment of the Pax7-dependent chromatin landscape. Thus, in both cases, *Pax7*- and *Tpit*-double-knockout samples cluster closely with the *Tpit* single knockout (Fig. [5c, f](#Fig5){ref-type="fig"}), showing that loss of both factors does not have a greater impact on accessibility than the loss of Tpit alone.Fig. 5Pax7-dependent chromatin landscape requires Tpit. **a** Dispersion plot showing average assay for transposase-accessible chromatin using sequencing (ATACseq) *r*log values (assessed by Deseq2) over the log 2 fold changes (FCs) of *Tpit* heterozygote versus *Tpit* knockout IL at all accessible regions. Differentially accessible regions (*p* value \<0.05 and log 2 FC \>±1 as computed by Deseq2) are shown as red circles. **b** Read density heatmaps showing ATACseq signals at Tpit-dependent chromatin opening (log 2 FC \<−2) in the indicated mouse genotypes. **c** Principal component analysis of the ATAC signals at all 16,024 Tpit-regulated chromatin opening across the tested genotypes. **d** Dispersion plot showing average ATACseq *r*log values (assessed by Deseq2) over the log 2 fold changes of *Pax7* heterozygote versus *Pax7-*knockout IL at all accessible regions. Differentially accessible regions (*p* value \<0.05 and log 2 FC \>±1 as computed by Deseq2) are shown as red circles. **e** Read density heatmap showing ATACseq signals at Pax7-dependent chromatin opening (log 2 FC \<−2) in the indicated mouse genotypes. **f** Principal component analysis of the ATAC signals at all 7058 Pax7-regulated chromatin opening across the tested genotypes. **g** Hi-C interaction map (top) from mouse embryonic stem (ES) cells^[@CR42]^ around the *Pcsk2* locus showing the boundaries of the *Pcsk2* TAD. Genome browser views (bottom) of the ATACseq profiles in purified pituitary cells and ILs of the indicated genotypes at the corresponding genome location. **h** t-SNE map colored for single-cell *Pcsk2* expression showing no *Pcsk2* expression in corticotropes, highest expression in melanotropes, and weak expression in gonadotropes. **i** Co-staining immunofluorescence for Pax7 (red) and PC2 (green) of *Tpit* heterozygote and *Tpit* knockout pituitaries from 5 days postnatal mice. Bars represent 50 μM

To assess the biological basis of this co-dependency, we focused on the *Pcsk2* gene, encoding the PC2 protein, a hallmark of melanotrope identity. We previously showed strong Pax7 dependency for chromatin opening of an upstream enhancer^[@CR12]^ together with multiple distal elements that are ATACseq sensitive in a lineage-specific manner. Interestingly, this melanotrope-specific chromatin accessibility is confined within a topologically associated domain (TAD) and stops at the border of this TAD (Fig. [5g](#Fig5){ref-type="fig"}); similar TAD-wide opening was observed at the *Drd2* and *Grik1* loci (Supplementary Fig. [5g](#MOESM1){ref-type="media"}). In accordance with the role of Pax7 for *Pcsk2* expression in melanotropes, we found that this TAD-wide chromatin opening does not occur in *Pax7−/−* animals. Consistent with our previous observation that Pax7-dependent access also depends on Tpit, chromatin opening within this TAD does not take place in *Tpit−/−* and in *Pax7−/−;Tpit−/−* animals. Thus, Tpit is required for opening of the *Pcsk2* TAD. It is noteworthy that *Pcsk2* is also expressed, albeit at low levels, in gonadotropes (Fig. [5h](#Fig5){ref-type="fig"}). This gonadotrope pattern of *Pcsk2* expression is also found in the *Tpit−/−* IL cells that have switched fate^[@CR12]^; these cells occupy the dorsal side of the *Tpit−/−* mutant IL (Fig. [5i](#Fig5){ref-type="fig"}). In contrast, the ventral side of the same *Tpit−/−* IL harbors Pax7-positive cells that fail to express Pcsk2 (Fig. [5i](#Fig5){ref-type="fig"}). This confirms that Pax7 functionally requires Tpit to establish melanotrope identity.

Productive Pax7 pioneer action in Tpit-positive cells {#Sec8}
-----------------------------------------------------

In order to evaluate the chromatin-binding properties of Pax7 and Tpit, we compared their binding properties to those of a pituitary nonpioneer factor Pitx1 and to two pioneer factors, Neurod1 that is expressed in pituitary corticotropes^[@CR20],[@CR21]^, and the reprogramming factor Sox2^[@CR6]^. The heatmaps of ATACseq signals for all binding sites of these five TFs in AtT-20 cells reveal striking differences between the profiles of Tpit and Pitx1, compared to those of the pioneers, Neurod1, Pax7, and Sox2 (Fig. [6a](#Fig6){ref-type="fig"}). Whereas Tpit and Pitx1 mostly (\~95% of all sites) bind to sites that are open (i.e., have a detectable ATACseq signal), a significant proportion of the pioneer binding sites have little or no ATACseq; thus, for Pax7 and Neurod1, \~30% of binding sites are in inaccessible chromatin, whereas this is true for \~60% of all Sox2 binding sites. The ability to bind closed chromatin (ATAC-negative) appears to be a common property of the three pioneer factors in contrast to the nonpioneers Tpit and Pitx1.Fig. 6Pax7 binding on closed chromatin is only productive in Tpit-expressing cells. **a** Read density heatmaps of assay for transposase-accessible chromatin using sequencing (ATACseq) signal density in a 4 kb window centered on binding sites for the indicated factors. The heatmaps are ranked by their decreasing ATACseq central (200 bp) read densities. **b**, **c** Genome browser views of ATACseq profiles in AtT-20 and αT3 cells at the Tpit (**b**) and SF1 (**c**) loci. **d** Dispersion plots of central (200 bp) ATACseq read densities in Neo (*x*-axis) versus Pax7 (*y*-axis) expressing AtT-20 (left) and αT3 cells (right) at all Pax7 binding sites in the indicated cell lines. Colored dots represent sites with significantly stronger signals after Pax7 expression. **e** Dispersion plots of ATACseq read densities in Pax7-expressing cells (*x*-axis) over Pax7 chromatin immunoprecipitation sequencing (ChIPseq) read densities (*y*-axis) in AtT-20 (left) and αT3 cells (right) at Pax7 binding sites with no ATACseq signal (\<1 reads per kilobase of transcript, per million mapped reads (RPKM) in Neo cells) before Pax7 expression. **f**, **g** Boxplots of Tpit ChIPseq (**f**) and ATACseq (**g**) read densities in Neo- and Pax7-expressing AtT-20 cells at Pax7 sites without ATACseq signal (\<1 RPKM in Neo cells) before Pax7 expression subdivided into Tpit-bound (\>1 RPKM in Pax7-expressing cells, blue) and not bound by Tpit (\<1 RPKM in Pax7-expressing cells, gray). Right panels: in light blue, Tpit binding and ATACseq signals are shown at sites bound by Tpit before Pax7 expression, that is, at open chromatin sites (without filtering the initial ATAC signal). Center lines show medians; box limits indicate the 25th and 75th percentiles; whiskers extend to 1.5 times the interquartile range from the 25th to 75th percentiles. **h** Tpit motif density at Pax7 sites without ATACseq signal before Pax7 expression subdivided into Tpit-bound (\>1 RPKM in Pax7-expressing cells, blue) and not bound by Tpit (\<1 RPKM in Pax7-expressing cells, gray). **i** Pull-down assay of in vitro translated Tpit interaction with MBP-Pax7, but not with MBP-βGal

In order to reveal the contribution of Tpit to chromatin pioneering by Pax7, we compared the impact of Pax7 expression in two different pituitary cell lines, one that expresses Tpit (AtT-20) and one that does not (αT3). In agreement with expression data, the *Tpit* locus exhibits ATACseq signals in AtT-20 cells, but not in αT3 cells (Fig. [6b](#Fig6){ref-type="fig"}), whereas the locus for the gonadotrope-specific regulator *SF1* presents ATACseq signals in αT3, but not in AtT-20 cells (Fig. [6c](#Fig6){ref-type="fig"}).

We looked at the chromatin accessibility by ATACseq before/after Pax7 expression^[@CR12],[@CR13]^ in both lineages and found that in AtT-20 cells Pax7 binding leads to opening of 6607 regions. In contrast, only 661 sites are opened following Pax7 expression in αT3 cells and this opening is of greater magnitude in AtT-20 cells (Fig. [6d](#Fig6){ref-type="fig"}). Thus, the expression of Pax7 in αT3 cells does not lead to efficient chromatin opening. We have previously identified steps of pioneering as follows: initial weak binding to closed enhancers (\<30 min), stabilization of pioneer binding followed by chromatin opening^[@CR13]^. Failure to perform any of these three steps should impede Pax7 pioneering. To identify which specific step limits Pax7 pioneering in αT3 cells, we compared Pax7 binding in AtT-20 and αT3 cells (Supplementary Fig. [6](#MOESM1){ref-type="media"}). Pax7 enrichment is similar in both AtT-20 and αT3 cells (Supplementary Fig. [6a](#MOESM1){ref-type="media"}) allowing quantitative comparisons of Pax7 binding in the two lineages. Pax7 is mostly binding in large domains that are depleted of the H3K27me3 mark and some of these are cell-specific suggesting a role of heterochromatin to limit Pax7 binding (Supplementary Fig. [6b](#MOESM1){ref-type="media"}). Comparison of Pax7 binding sites in both cells revealed a large number of common sites and some lineage-specific sites (Supplementary Fig. [6b](#MOESM1){ref-type="media"}): for the αT3-specific sites, some sites (the \> 50kb distant peaks) exhibit higher levels of the repressive chromatin marks H3K9me3 and H3K27me3 (Supplementary Fig. [6b](#MOESM1){ref-type="media"}) as observed for some AtT-20-specific sites (Supplementary Fig. [6c](#MOESM1){ref-type="media"}), while other αT3-specific sites (the \<20 kb distant sites) are enriched for binding sites of the gonadotrope-specific TFs SF1 and NeuroG2 (Supplementary Fig. [6d, e](#MOESM1){ref-type="media"}). Restrictions to Pax7 binding in different lineages thus appear to include chromatin status and/or presence of binding sites for lineage-restricted factors as previously shown for other pioneers^[@CR22],[@CR23]^.

We then extracted all Pax7 sites bound to closed chromatin in AtT-20 and in αT3 (Fig. [6e](#Fig6){ref-type="fig"}). In both AtT-20 and αT3 cells, there are sites with strong and low binding signals. This suggests that Pax7 is able to bind strongly to closed chromatin in both cell context. However in AtT-20 cells, Pax7 binding strength correlates (*r*^2^ = 0.41) with accessibility after Pax7 expression, whereas in αT3 cells there is no correlation (*r*^2^ = 0.09) between Pax7 binding and post-Pax7 chromatin opening (Fig. [6e](#Fig6){ref-type="fig"}). We identified a subset of heterochromatin Pax7-bound sites based on their ability for Tpit binding after Pax7 expression; these sites are not bound by Tpit in the absence of Pax7 (Fig. [6f](#Fig6){ref-type="fig"}) and become accessible in the presence of Tpit and Pax7 (Fig. [6g](#Fig6){ref-type="fig"}). In contrast, this dependence is not observed at sites that are already in open chromatin (Fig. [6f, g](#Fig6){ref-type="fig"}, right panels). It is noteworthy that only these newly accessible sites contain the Tpit DNA-binding motif (Fig. [6h](#Fig6){ref-type="fig"}). This suggests that Pax7-dependent Tpit binding also depends on the Tpit DNA motif. Notwithstanding, Pax7 and Tpit interact directly in vitro as shown in pull-down assays (Fig. [6i](#Fig6){ref-type="fig"}). The interaction between the two factors may also contribute to their cooperation. This suggests that Pax7's ability to bind strongly to closed chromatin is not dependent on cell-specific factors and that stable binding is not sufficient to drive chromatin opening. During melanotrope differentiation, this pioneer-dependent chromatin opening also requires Tpit.

Discussion {#Sec9}
==========

Pioneer factors are coined as "factors that can open closed chromatin." This label implied that pioneers were expected to directly provide this ability. The present work shows that there can be division of labor between pioneer and nonpioneer factors: in the case of Pax7 and Tpit, the former recognizes and engages pioneering sites and the latter provides the chromatin opening ability. Indeed, we show that Tpit is required for chromatin opening at sites that must first be pioneered by Pax7, and we did not find evidence for the reverse. While we envision that this is made possible by Tpit-dependent recruitment of chromatin remodeling machineries, the finding clearly circumscribes the unique features of the Pax7 pioneer function. Namely, the unique aspect of pioneer action is the ability to bind DNA sites within closed chromatin that are inaccessible to probing by techniques such as ATACseq; this appears to be a property shared with other pioneers such as Sox2, and NeuroD1 (Fig. [6a](#Fig6){ref-type="fig"}) in contrast to nonpioneer factors such as Tpit or Pitx1.

While the simplest interpretation of this model may predict pioneer access to all its genome-wide target sites, we found that this is not the case as we compared Pax7 binding and associated chromatin access (ATAC) changes in two different pituitary cell lineages (Fig. [6](#Fig6){ref-type="fig"} and Supplementary Fig. [6](#MOESM1){ref-type="media"}). This differential Pax7 binding and action suggests that there are permissive and non-permissive forms of heterochromatin for Pax7 action. The heterochromatin sites susceptible to Tpit-assisted Pax7 pioneering include isolated putative enhancers (Supplementary Fig. [7](#MOESM1){ref-type="media"}) and sites that are within TADs (e.g., the melanotrope-specific *Pcsk2* TAD) where the entire TAD access is opened by Pax7 (Figs. [5g](#Fig5){ref-type="fig"} and [7a, b](#Fig7){ref-type="fig"}). The mechanistic relationship between Pax7 opening of isolated enhancers compared to entire TADs remains elusive.Fig. 7Pioneer action of Pax7. Cooperative chromatin opening by the pioneer Pax7 and the nonpioneer factor Tpit. The heterochromatin target sites of pituitary Pax7 pioneer action typically contain Pax7 DNA binding sites together with Tpit binding sites within a few hundred bp of each other. **a**, **b** Schematic representation of chromatin accessibility (**a**) assessed by assay for transposase-accessible chromatin using sequencing (ATACseq) at a pituitary melanotrope-specific TAD containing the *Pcsk2* gene (red domain). This domain presents multiple ATACseq peaks in wild-type melanotrope of the pituitary intermediate lobe (IL). This chromatin accessibility is not observed in cells of other pituitary lineages or in mutant ILs of single or double mutants for *Pax7* and/or *Tpit* (**b**). Similar observations were made for the *Pcsk2* (Fig. [5g](#Fig5){ref-type="fig"}), *Drd2* and *Grik1* loci (Supplementary Fig. [5g](#MOESM1){ref-type="media"})

For Pax7, we have shown that this initial binding to closed heterochromatin (Supplementary Fig. [7](#MOESM1){ref-type="media"}) is rapid (within 30 min) and that the first detectable change in chromatin structure at these binding sites is revealed by stabilization (within 24 h) of Pax7 binding^[@CR13]^. This stabilization precedes chromatin opening (revealed by ATACseq). Here, we find that strong Pax7 binding occurs even in the absence of Tpit (i.e., in αT3 cells, Fig. [6e](#Fig6){ref-type="fig"}): this excludes Tpit's involvement in Pax7 stabilization of binding. Unfortunately, we could not validate this conclusion in vivo because the small size of the *Tpit−/−* IL does not permit assessment of Pax7 binding in the absence of Tpit. The next step of pioneer action, namely chromatin opening, requires Tpit as it does not occur in αT3 cells. The recruitment of Tpit at a subset of Pax7 closed chromatin binding sites that have a Tpit DNA binding site in the vicinity results in chromatin opening (Supplementary Fig. [7](#MOESM1){ref-type="media"}). It would thus be the combined interaction of Pax7 with Tpit together with the latter's ability to bind its DNA site exposed through the initial action of Pax7 that altogether would lead to completion of pioneer action with Tpit bringing in the chromatin remodeling ability. With these interdependent functions, the cooperation between pioneer and nonpioneer factors provides robust stringency and a fail safe mechanism for triggering chromatin opening at a very specific subset of Pax7 sites and domains (Fig. [7](#Fig7){ref-type="fig"} and Supplementary Fig. [7](#MOESM1){ref-type="media"}).

The requirement for DNA binding sites for both Pax7 and Tpit at the Pax7 pioneered enhancers is reminiscent of the action of other pioneers where two different pioneers cooperate for chromatin opening. For example, the pluripotency factors cooperate with each other to facilitate the binding of other and binding of multiple pioneers is required at some sites to drive chromatin opening^[@CR7],[@CR23]^. Also, there is cooperation between FoxA1 and GATA4 for chromatin binding^[@CR24]^. Foxa1 also facilitates the binding of the estrogen receptor by opening chromatin^[@CR25],[@CR26]^. Reciprocally, another study showed that steroid receptors can facilitate the binding of Foxa1^[@CR27]^. This suggests that in the case of steroid receptors and Foxa1 both can play the role of pioneer at specific subsets of their targets. To our knowledge, the required participation of a nonpioneer for pioneer-driven chromatin opening has not been shown so far.

Prior data indicated that pioneer binding precedes gene activation, for example, the binding of FoxA at liver targets precedes their activation^[@CR28]^. More recently, Grainy head binding at pioneer sites was shown to determine chromatin opening (ATAC signal), but not enhancer activity^[@CR29]^.

The required cooperation between pioneer and nonpioneer factors for implementation of a specific genetic program ensures specificity of action. For example, Pax7 is also involved in cell fate specification in muscle and neural tissues in addition to pituitary, but its interdependent action with Tpit in the pituitary ensures that Pax7 access to pituitary-unrelated sites may not result in chromatin opening in the absence of Tpit. This essential cooperation between specification and determination factors provides robustness for lineage identity by preventing mis-activation of inappropriate gene regulatory networks. This limitation to the capacity of pioneer factors would allow specific combinations of pioneers and nonpioneers to activate different regulatory networks and explain the wide variability in targets depending on the same pioneer factor in different contexts.

Methods {#Sec10}
=======

Mice, tissues, and cell culture {#Sec11}
-------------------------------

For single-cell RNAseq, a 4-month-old male C57Bl/6 mouse pituitary was used; cells were dissociated as described below. For ATACseq, FACS-purified pituitary cells are isolated from 3- to 5-month-old adult LH-cerulean^[@CR18]^ or POMC-EGFP^[@CR19]^ C57Bl/6 transgenic pituitaries. ATACseq was performed in duplicates for each genotypes of *Pax7*^[@CR30]^ and *Tpit*^[@CR9]^ knockouts. Each replicate used a pool of four dissected intermediate pituitaries from 8- to 20-day-old mice in mixed Balb/c and 129sv backgrounds. FACS analyses of intermediate and anterior pituitaries used 15--20-day-old *Pax7*-knockout mice harboring the *POMC-EGFP* transgene in a mixed 129sv and C57Bl/6 background. All animal experimentation was approved by the IRCM Animal Ethics Committee in accordance with Canadian regulations.

AtT-20 cells (obtained from the late E. Herbert in 1981 and subsequently maintained in our laboratory, with yearly negative mycoplasma tests) and αT3 cells were cultured in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% fetal bovine serum (FBS) and antibiotics (penicillin/streptomycin).

For generation of stable Neo-, Pax7-, and Sox2-expressing cells, expression vectors constructed in the pLNCX2 vector were described previously^[@CR12]^. Retroviruses were packed using the EcoPack 2-293 cells (Clontech, Mountain View, CA) and infections were performed as described^[@CR12]^. Selection of retrovirus-infected cell populations was achieved with 400 μg/ml geneticin (Gibco, 11811-031). Resistant colonies were pooled to generate retrovirus-infected populations of more than 1000 independent colonies.

Pituitary intermediate and AL cell dissociation {#Sec12}
-----------------------------------------------

After dissection, mouse pituitary intermediate or ALs were dissociated as described^[@CR18]^. Briefly, dissected pituitaries were separated into intermediate and ALs and kept during the dissections in 300 µl of dissection buffer (DMEM, 10% FBS, HEPES 10 mM, and DNase 100 U/ml). ALs were cut in pieces using a scalpel to facilitate tissue dissociation and digested at 37 °C using 5 mg/ml trypsin for 10 min. We then added 2 mM EDTA and incubated 5 min more. Ten percent FBS was then added to stop the dissociation and samples were centrifuged and then resuspended into 150 µl of phosphate-buffered saline (PBS) 1×, 0.1% bovine serum albumin (BSA), 10 mM HEPES, and for FACS analyses.

3′ End single-cell RNAseq {#Sec13}
-------------------------

Dissociated pituitary cells were diluted at 500 cells per µl and processed using Chromium Single Cell 3′ v2 Reagent (10x Genomics, Pleasanton, CA) following the manufacturer recommendation. Briefly, cells were passed on the channel and 9269 cells were recovered. Pituitary cells were partitioned into gel beads in emulsion for cell lysis and barcoded with oligo-dT priming and reverse transcribed. cDNA library was amplified fragmented and size selected. Samples were controlled at multiple steps during the procedure by running on BioAnalyzer. Libraries were sequenced on Hiseq 4000 with 100 bp paired-end reads.

Purification of pituitary lineages by FACS {#Sec14}
------------------------------------------

Dissociated anterior pituitary cells from 62 LH-cerulean mice^[@CR18]^ were sorted using FACSAria instrument (BD) and the gate used to define cerulean-positive versus -negative cells were defined by first assessing autofluorescence of WT mice of the same strain, C57/Bl6. Cerulean-positive and -negative cells constituted the gonadotrope and AL samples, respectively, that were used in this study.

FACS analyses {#Sec15}
-------------

Dissociated anterior or intermediate pituitaries from WT or *Pax7*-knockout mice crossed with the POMC-EGFP transgene were analyzed using the FACSCalibur cell analyzer (BD Bioscience). EGFP levels were quantified together with FSC as an indicator of cell size and SSC as an indicator of granularity for both high and low EGFP-expressing cells. Experiments were repeated on three *Pax7*-knockout and 5 WT littermates in a mixed C57/Bl6 and 129sv background.

Immunohistofluorescence {#Sec16}
-----------------------

Immunohistofluorescence was performed on PFA-fixed paraffin sections as described^[@CR31]^. Briefly, 5-day-old *Tpit*-knockout and WT pituitaries were dissected, fixed in 4% paraformaldehyde (PFA), embedded in paraffin, and cut into 5-µm-thick sections. The following antibodies were used for immunohistofluorescence: Pax7 (DSHB AB_528428) and PC2 (a gift of Dr. Nabil Seidah, IRCM, Montreal).

ATACseq {#Sec17}
-------

All ATACseq samples were processed as previously described^[@CR13]^. Briefly, 50,000 cells were washed in PBS and incubated on ice for 30 min in a hypotonic cell lysis buffer (0.1% (w/v) sodium citrate tribasic dehydrate and 0.1% (v/v) Triton X-100) and centrifuged (5 min at 2000 × *g* at 4 °C). Cells were then incubated 30 min on ice in cell lysis buffer (10 mM Tris-HCl, pH 7.4, 10 mM NaCl, 3 mM MgCl~2~, 0.1% (v/v) IGEPAL CA-630. After centrifugation (5 min at 2000 × *g* at 4 °C), the nuclei pellets were resuspended in Transposase Master Mix (1.25 µl 10× TD buffer, 5 µl H~2~O, and 6.5 µl of Tn5: Illumina Nextera Kit; FC-121-1031) and incubated for 30 min at 37 °C. Samples were purified using the DCC (dicyclohexylcarbodiimide) purification columns (Zymo). The eluted DNA was barcoded for multiplexing of samples using Nextera barcodes and PCR enriched using the Phusion kit. Libraries were recovered with GeneRead Purification columns. Samples were then evaluated by qPCR to test enrichments and sequenced on Illumina Hiseq 2500 with 50 or 125 bp paired-end reads according to Illumina's recommendation.

ChIPseq {#Sec18}
-------

Chromatin immunoprecipitation sequencing (ChIPseq) was performed as previously described^[@CR32]^. At least three immunoprecipitations were pooled per ChIP experiments. Library and flow cells were prepared by the IRCM Molecular Biology Core Facility according to Illumina's recommendations and sequenced on Illumina Hiseq 2500. The following antibodies were used for ChIPseq: FlagM2 (Sigma F3165), Neurod1^[@CR33]^, and Sox2 (Ab59776, Abcam).

Pull-down assay {#Sec19}
---------------

MBP fusion proteins coupled to maltose amylose beads were produced as described^[@CR34]^. ^35^S-labeled proteins were synthesized in vitro using the TNT T7 Quick for PCR DNA Kit (Promega, L5540). Labeled proteins were incubated with MBP-tagged proteins in TNEN~50~ (50 mM Tris pH 7.5, 5 mM EDTA, 50 mM Nacl, 0.1% NP-40) with 1 mM phenylmethylsulfonyl fluoride and 2% BSA for 4 h at 4 °C. Beads were washed three times with 1 ml TNEN~125~. Bound proteins were resolved by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and visualized by autoradiography.

Data analyses {#Sec20}
-------------

For single-cell RNAseq analyses, reads were aligned on the mm10 mouse reference genome using the default parameters of Cell Ranger v2.1.1 (10X Genomics) to generate unique molecular identifier counts for each genes across the 9269 cells that were profiled. We obtained an average of 25,220 reads per cell and we detected 1807 median genes per cell. Using the Cell Ranger pipeline with default parameters, we generated a gene-barcode matrix, principal component analysis, and dimensionality reduction using the t-SNE algorithm. Unbiased clustering of single cells was performed using Cell Ranger, which combines *k*-means clustering and graph-based clustering uncovering 12 clusters. We used Loupe Cell Browser (10X Genomics) to visualize the t-SNE plot with colored cell according to their assigned cluster or colored by gene UMI. Loupe Cell Browser was also used to perform local differential expression analyses of clusters 1, 2, 4, 5, 7, and 8. Cluster corresponds to four islands of cells that each express a different hormone gene, Gh, Prolactin, Lh, and POMC. Differential analysis of the four sub-clusters against their matching hormone-expressing cell cluster showed that mitochondrial RNAs are down-regulated in each case and this is an indicator of low-quality cells^[@CR16]^. Thus to avoid confounding effects, cluster 3 was not included in all further analyses.

ATACseq reads were trimmed, if required, to obtain a read length of 50 bp and aligned to the mm10 mouse reference genome using Bowtie v2.3.1^[@CR35]^ with the following parameters: --fr--no-mixed--no-unal. Sam files were converted into tag directories using HOMER v4.9.1^[@CR36]^ and into bam files using Samtools v1.4.1^[@CR37]^ view function. Tag directories were used to generate the normalized BigWig files with HOMER using the command makeUCSCfile with the parameters: -fsize 1e20 -res 5 -fragLength 100. Peaks were identified by comparing each sample replicate to sequenced input DNA from pituitary using MACS v2.1.1.20160309^[@CR38]^ callpeak function using the parameters: -f BAMPE--bw 250 -g mm--mfold 10 30 -p 1e-5. Peaks with an associated *p* value \<10^−5^ were kept. First we compared ATACseq profiles of purified pituitary cells: melanotrope (2 replicates), corticotropes (2 replicates), gonadotropes (1 replicate), and whole AL (1 replicate). Peaks from all datasets from purified pituitary cells were merged using HOMER v4.9.1 mergePeaks tool to obtain a file with all unique positions from the ATACseq datasets. This list was clustered by *k*-means in two clusters for each sample giving the 16 combinations of ATAC clustering as represented in a heatmap in Fig. [2b](#Fig2){ref-type="fig"}. Peaks from all datasets from the various genotypes of *Pax7*- and *Tpit*-knockout ILs were merged together using HOMER v4.9.1 mergePeaks tool to obtain a file with all unique IL positions from all ATACseq datasets. ATACseq signals were quantified in these different datasets using the analyzeRepeats.pl HOMER command and differential accessibility analyses was performed using getDiffExpression.pl with default parameters which uses Deseq2. Peaks showing a differential *p* value \<0.05 and a fold change of 2-fold or more were considered differentially accessible.

We mapped ChIPseq reads on the mouse genome assembly mm10 by using Bowtie v1.1.2 with the following settings: bowtie -t -p 4--trim5 1--best mm10 --S. Sam files were converted into tag directories using HOMER v4.9.1 and into bam files using Samtools v1.4.1 view function. Peaks were identified by comparing each sample to its control (IP Flag for Pax7, IP IgG for others) using MACS v2.1.1.20160309 callpeak function using the parameters:--bw 250 -g mm--mfold 10 30 -p 1e-5. Peaks with an associated *p* value \<10^−5^ were kept.

Heatmaps and average profiles were generated using Easeq^[@CR39]^. We used IGV^[@CR40]^ to visualize the BigWig files on the genome. Principal component analysis and clustered Heatmap associated with dendrograms from Figs. [1d](#Fig1){ref-type="fig"} and [5c, f](#Fig5){ref-type="fig"} were generated using ClustVis^[@CR41]^.

Reporting summary {#Sec21}
-----------------

Further information on research design is available in the [Nature Research Reporting Summary](#MOESM2){ref-type="media"} linked to this article.
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